Daclatasvir dihydrochloride(CAS: 1009119-65-6)

Daclatasvir dihydrochloride is a crystalline compound with a molecular weight of approximately 502.7 g/mol. It has a high solubility in water and is relatively stable under normal conditions. The compound exhibits moderate reactivity with acidic and basic substances. Its dihydrochloride form enhances its water solubility, making it more bioavailable.

Daclatasvir dihydrochloride is synthesized through a multi-step process involving condensation reactions, amidation, and hydrochloridation steps. The key reaction involves the coupling of a protected amino acid derivative with an aromatic ring, followed by deprotection and hydrochloridation. The process yields a highly selective and pure product with good yield.

Daclatasvir dihydrochloride is primarily used in the pharmaceutical industry for the treatment of hepatitis C. It is also of interest in research for its antiviral properties, making it relevant to the bioscience and biotechnology sectors. Its synthetic nature also makes it relevant to chemical research and development.

When handling Daclatasvir dihydrochloride, it is essential to wear appropriate personal protective equipment (PPE) such as gloves and safety glasses. It should be stored in a cool, dry place to prevent degradation. In case of a spill, it should be handled in a fume hood to avoid inhalation. It is crucial to consult the Safety Data Sheet (SDS) for detailed handling and disposal procedures.